T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

NCT00602693 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma
Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: umbilical cord blood transplantation
DRUG: Allopurinol
DRUG: fludarabine phosphate
DRUG: Cyclophosphamide
RADIATION: Total body irradiation
BIOLOGICAL: Treg infusion
DRUG: Sirolimus

Sponsor

Masonic Cancer Center, University of Minnesota